Cytek BioSciences, Inc. (CTKB) Social Stream
Cytek Biosciences Inc (CTKB) Price Targets From Analysts
Use the tables below to see what analysts covering Cytek Biosciences Inc think about its future price and what recommendations they have for investors and traders.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Over the past 73 days, CTKB's average upside potential has been 9.72%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
CTKB Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- The variance in analysts' estimates of CTKB is lower than just about 100% of all US stocks.
- Cytek Biosciences Inc's number of analysts covering the stock is greater than 3.62% of stocks in the mid market cap category.
- Cytek Biosciences Inc's average analyst price target is greater than 20% of Measuring and Control Equipment stocks.
- The upside potential (average analyst target price relative to current price) of CTKB is greater than 77.55% of stocks in the mid market cap category.
What is the outlook for CTKB? Use POWR Ratings for clearer insight into price direction.